Page last updated: 2024-12-05

cuprizone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cuprizone, also known as bis(cyclohexanone)oxalyldihydrazone, is a copper chelator that induces demyelination in the central nervous system. It is synthesized through the reaction of cyclohexanone with oxalyldihydrazide. Cuprizone is widely used in animal models of multiple sclerosis (MS) due to its ability to selectively damage oligodendrocytes, the cells responsible for producing myelin. Studies have shown that cuprizone treatment results in a decrease in myelin basic protein (MBP) and other myelin-associated proteins, leading to axonal damage and neurological dysfunction. The importance of cuprizone research lies in its ability to provide insights into the mechanisms of demyelination and remyelination in MS. By studying the effects of cuprizone on the central nervous system, researchers can develop potential therapeutic targets for treating MS and other demyelinating diseases.'

Cross-References

ID SourceID
PubMed CID9723
CHEBI ID177802
SCHEMBL ID80049
MeSH IDM0005418

Synonyms (49)

Synonym
CHEBI:177802
cuprizon
biscyclohexanone oxalyldihydrazone
nsc-4283
nsc4283
biscyclohexanone oxaldihydrazone
oxalic acid, bis(cyclohexylidenehydrazide)
oxalic acid bis(cyclohexylidenehydrazide)
ethanedioic acid, bis(cyclohexylidenehydrazide)
oxalic acid bis(cyclohexylidene hydrazide)
cuprizone ,
370-81-0
cuprizane
nsc 4283
ethanedioic acid, bis(cyclohexylidene hydrazide)
n,n-oxalylbis(cyclohexanone hydrazone)
brn 2388004
einecs 206-729-2
CBDIVE_008940
inchi=1/c14h22n4o2/c19-13(17-15-11-7-3-1-4-8-11)14(20)18-16-12-9-5-2-6-10-12/h1-10h2,(h,17,19)(h,18,20
bis(cyclohexanone)oxaldihydrazone
oxalic acid -bis(cyclohexanylidenehydrazide)
bis(cyclohexylidenehydrazide)-ethanedioic acid
n,n'-bis(cyclohexylideneamino)oxamide
STK025690
n'~1~,n'~2~-dicyclohexylideneethanedihydrazide
cupferazone
bis(cyclohexanone) oxalyldihydrazone
B0476
oxalic bis(cyclohexylidenehydrazide)
AKOS003888624
unii-5n16u7e0ao
ethanedioic acid, 1,2-bis(2-cyclohexylidenehydrazide)
5n16u7e0ao ,
4-07-00-00025 (beilstein handbook reference)
FT-0624121
n',n'-dicyclohexylideneethanedihydrazide
SCHEMBL80049
DSRJIHMZAQEUJV-UHFFFAOYSA-N
mfcd00001659
bis(cyclohexanone) oxaldihydrazone
chromium(iii) ionophore iii, selectophore(tm), function tested
bis(cyclohexanone)oxaldihydrazone, for spectrophotometric det. of cu, >=99.0%
n'1,n'2-dicyclohexylideneoxalohydrazide
DTXSID30861909
H11298
Q27262585
AS-75478
CS-0197959

Research Excerpts

Overview

Cuprizone (CPZ) is a copper chelator used to produce a reversible oligodendrocytopathy in animals. The cuprizone model is a widely used model to study the pathogenesis of MS. Cuprizone is a neurotoxicant causing neurodegeneration through enzymes inhibition and oxidative stres.

ExcerptReferenceRelevance
"Cuprizone is a copper-chelating agent that induces pathology similar to that within some multiple sclerosis (MS) lesions. "( Cuprizone feed formulation influences the extent of demyelinating disease pathology.
Anyaegbu, C; Bartlett, CA; Fitzgerald, M; Hellewell, SC; Lins, B; McGonigle, T; Papini, M; Toomey, LM; Warnock, A; Wright, AJ, 2021
)
3.51
"Cuprizone (CPZ) is a copper-chelator and toxic to mitochondria. "( Cuprizone-induced dopaminergic hyperactivity and locomotor deficit in zebrafish larvae.
Hong, L; Liu, M; Xu, H; Yang, F; Yu, X; Zhang, W; Zheng, M; Zheng, P, 2022
)
3.61
"Cuprizone (CPZ) is a copper chelator used to produce a reversible oligodendrocytopathy in animals, which has some similarities to the pathology found in human multiple sclerosis (MS). "( Defining milestones for the study of remyelination using the cuprizone mouse model: How early is early?
Almeida, L; Ambrósio, AF; Castelo-Branco, M; Dinis, J; Henriques, S; Madeira, MH; Martins, J; Palavra, F; Pereira, FC; Petrella, L; Reis, F; Santiago, R; Sereno, J; Viana, SD, 2022
)
2.41
"The cuprizone model is a widely used model to study the pathogenesis of multiple sclerosis (MS). "( Cuprizone feeding induces swollen astrocyte endfeet.
Bonzheim, I; Fallier-Becker, P; Pfeiffer, F, 2022
)
2.72
"Cuprizone (CPZ) is a neurotoxic agent that is used to induce demyelination and neurotoxicity in rats. "( Sulforaphane, an Nrf-2 Agonist, Modulates Oxidative Stress and Inflammation in a Rat Model of Cuprizone-Induced Cardiotoxicity and Hepatotoxicity.
Ibrahim Fouad, G, 2023
)
2.57
"The cuprizone model is an effective tool for studying demyelination and remyelination processes in the brain, but blood-brain barrier (BBB) integrity in the cuprizone model is still a topic for debate."( Localized Increased Permeability of Blood-Brain Barrier for Antibody Conjugates in the Cuprizone Model of Demyelination.
Abakumov, M; Abakumova, T; Chekhonin, V; Gubskii, I; Gurina, O; Ionova, K; Koshkin, P; Kuzkina, A; Melnikov, P; Nukolova, N; Pozdeeva, D, 2023
)
1.61
"Cuprizone is a copper chelator that is well characterized by microgliosis and astrogliosis and is reproducible for demyelination and remyelination."( Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling.
Abdel-Maged, AE; Awad, AS; Azab, SS; Gad, AM; Mohamed, EA; Rashed, LA, 2020
)
1.53
"Cuprizone is a neurotoxicant causing neurodegeneration through enzymes inhibition and oxidative stress. "( Neurotherapeutic and antioxidant response of D-ribose-L-Cysteine nutritional dietary supplements on Alzheimer-type hippocampal neurodegeneration induced by cuprizone in adult male wistar rat model.
Afolayan, OO; Agie, JA; Fidelis, OP; Ogunlade, B, 2021
)
2.26
"Cuprizone (CPZ) is a copper chelator that selectively injures oligodendrocytes, and MK-801 is an antagonist of the N-methyl d-aspartate (NMDA) receptor."( Behavioral and neurobiological changes in a novel mouse model of schizophrenia induced by the combination of cuprizone and MK-801.
Gu, LH; Li, L; Li, XM; Ma, DL; Sun, ZY; Wang, MY; Yang, CC; Zhang, JW; Zhang, L, 2021
)
1.56
"The cuprizone model is a well-established and investigated paradigm to study demyelination and remyelination in rodents. "( An Alternative Cuprizone-Induced Demyelination and Remyelination Mouse Model.
Liu, A; Lu, J; Tattersall, D; Wang, J; Zhang, W; Zhen, W,
)
1.04
"The cuprizone model is an established mouse model of MS and causes demyelination and motor dysfunction and induces neuroinflammation, such as glial activation and pro-inflammatory cytokine production."( The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation.
Bosetti, F; Hashimoto, M; Ishikawa, M; Iwasa, K; Maruyama, K; Yamamoto, S; Yamashina, K; Yoshikawa, K, 2017
)
1.21
"Cuprizone (CZ) is a widely used copper chelating agent to develop non-autoimmune animal model of multiple sclerosis, characterized by demyelination of the corpus callosum (CC) and other brain regions. "( Cuprizone Administration Alters the Iron Metabolism in the Mouse Model of Multiple Sclerosis.
Abrahám, H; Ács, P; Horváth, A; Komoly, S; Miseta, A; Pandur, E; Sipos, K; Varga, E, 2018
)
3.37
"Cuprizone (CPZ) is a copper-chelating agent and has been shown to induce white matter damage in mice and rats. "( Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone.
Li, XM; Xu, H; Yang, HJ, 2014
)
2.06
"Cuprizone is a copper-chelating mitochondrial toxin that causes oligodendrocyte apoptosis and demyelination preferentially in the corpus callosum (CC) and the superior cerebellar peduncles, but not in the spinal cord (SC) of C57BL/6 mice. "( Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model.
Acs, P; Kalman, B; Komoly, S; Selak, MA, 2013
)
2.07
"Cuprizone (CPZ) model is a toxic demyelination model."( Cuprizone-induced demyelination in Wistar rats; electrophysiological and histological assessment.
Basoglu, H; Boylu, NT; Kose, H, 2013
)
2.55
"Cuprizone (CPZ) is a copper chelating agent able to selectively insult mature oligodendrocytes (OLs) in brains of rodents. "( Concurrent changes in ¹H MRS metabolites and antioxidant enzymes in the brain of C57BL/6 mouse short-termly exposed to cuprizone: possible implications for schizophrenia.
Peng, H; Wu, R; Xu, H; Xuan, Y; Yan, G, 2014
)
2.05
"Cuprizone is a copper chelating agent able to selectively damage the white matter in the mouse brain. "( Brain metabolite changes in subcortical regions after exposure to cuprizone for 6 weeks: potential implications for schizophrenia.
Dai, Z; Shen, Z; Wu, R; Xu, H; Xuan, Y; Yan, G; Zhang, G, 2015
)
2.1
"Cuprizone is a copper chelator and it has been hypothesized that it induces a copper deficiency in the brain, which leads to demyelination."( Altered transition metal homeostasis in the cuprizone model of demyelination.
Al-Ebraheem, A; Bock, NA; Farquharson, MJ; Lobo, L; Moldovan, N; Park, R, 2015
)
1.4
"Cuprizone is a copper-chelating agent and able to induce oligodendrocyte loss and demyelination in C57BL/6 mouse brain. "( The cuprizone-induced changes in (1)H-MRS metabolites and oxidative parameters in C57BL/6 mouse brain: Effects of quetiapine.
Huang, Q; Li, X; Wu, R; Xu, H; Xuan, Y; Yan, G, 2015
)
2.42
"Cuprizone is a copper chelator, which when supplemented to the normal food of C57BL/6J mice in a concentration of 0.2% leads to oligodendroglial loss, subsequent microglia and astrocyte activation, resulting in demyelination."( Investigation of Cuprizone Inactivation by Temperature.
Bleich, A; Gudi, V; Heckers, S; Held, N; Kronenberg, J; Skripuletz, T; Stangel, M, 2017
)
1.52
"Cuprizone intoxication is a common animal model used to test myelin regenerative therapies for the treatment of diseases such as multiple sclerosis. "( Cuprizone Intoxication Induces Cell Intrinsic Alterations in Oligodendrocyte Metabolism Independent of Copper Chelation.
Avila, R; Caporoso, J; Huang, H; Leeper, TC; Manandhar, E; Medicetty, S; Modarelli, DA; Shriver, LP; Taraboletti, A; Walker, T, 2017
)
3.34
"Cuprizone (CPZ) is a neurotoxic agent acting as a copper chelator. "( Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia.
Browning, R; Clough, RW; Li, XM; Wang, H; Xiao, L; Xu, H; Yang, HJ; Zhang, Y, 2009
)
2.07
"Cuprizone feeding is a commonly used model to study experimental de- and remyelination, with the corpus callosum being the most frequently investigated white matter tract. "( Regional differences between grey and white matter in cuprizone induced demyelination.
Gudi, V; Kotsiari, A; Koutsoudaki, PN; Moharregh-Khiabani, D; Skripuletz, T; Skuljec, J; Stangel, M; Trebst, C, 2009
)
2.04
"Cuprizone intoxication is a commonly used model of demyelination that allows the temporal separation of demyelination and remyelination. "( Proteomic analysis of demyelinated and remyelinating brain tissue following dietary cuprizone administration.
Broderick, CL; Duffin, KL; Higgs, RE; Saha, JK; Smith, RC; Werner, SR; Zhen, EY, 2010
)
2.03
"The cuprizone model is a model of de- and remyelination secondary to oligodendrocyte death, likely to be mediated by an inhibition of mitochondrial function. "( The cuprizone model: regional heterogeneity of pathology.
Bø, L; Myhr, KM; Mørk, SJ; Torkildsen, Ø; Wergeland, S, 2012
)
1.5
"The cuprizone model is a suitable animal model of de- and remyelination secondary to toxin-induced oligodendrogliopathy. "( Regional heterogeneity of cuprizone-induced demyelination: topographical aspects of the midline of the corpus callosum.
Awad, H; Beyer, C; Clarner, T; Kipp, M; Schmidt, T; Slowik, A, 2013
)
1.25
"The cuprizone model is a model for toxic demyelination."( The cuprizone model for demyelination.
Brunborg, LA; Bø, L; Myhr, KM; Torkildsen, O, 2008
)
1.38

Effects

Cuprizone intoxication has been used as a model for reversible demyelination in the CNS. The cuprizone reaction has been employed in colourimetric tests for the presence of trace levels of copper.

ExcerptReferenceRelevance
"Cuprizone (CPZ) has been used to produce demyelination which resembles demyelination in MS patients."( (R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut-microbiota-brain axis.
Chang, L; Hashimoto, K; Ma, L; Qu, Y; Shan, J; Tan, Y; Wan, X; Wang, X; Yang, Y, 2022
)
1.68
"The cuprizone reaction has been employed in colourimetric tests for the presence of trace levels of copper."( Synthesis and structural characterization of copper-cuprizone complexes.
George, GN; Nienaber, KH; Pickering, IJ; Pushie, MJ; Summers, KL, 2022
)
1.45
"The cuprizone (CPZ) model has been widely used to study MS as it mimics some characteristics of demyelination disease."( Cordycepin (3'-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination.
Bao, H; Chen, X; Du, J; Feng, L; Hou, Y; Jia, Y; Li, H; Luo, S; Wang, C; Wang, G; Xiao, C; Xiao, L; Xiao, Y; Yu, H; Zhang, D; Zhang, Y; Zhou, J; Zhu, K, 2019
)
1.21
"The cuprizone (CPZ) model has been widely used for the studies of de-and remyelination. "( Cyclin-dependent kinase inhibitor flavopiridol promotes remyelination in a cuprizone induced demyelination model.
Gao, Y; Jin, X; Li, Y; Liu, S; Mi, G; Yang, H; Yang, Z; Ye, E, 2016
)
1.22
"Cuprizone intoxication has been used as a model for reversible demyelination in the CNS. "( Rapid upregulation of the Pi isoform of glutathione-S-transferase in mouse brains after withdrawal of the neurotoxicant, cuprizone.
Cammer, W; Tansey, FA; Zhang, H, 1997
)
1.95

Actions

ExcerptReferenceRelevance
"Cuprizone is known to cause demyelination in Swiss mice, however, cuprizone-induced demyelination in C57BL/6 mice has not been previously described."( Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.
Hiremath, MM; Knapp, GW; Matsushima, GK; Saito, Y; Suzuki, K; Ting, JP, 1998
)
1.29

Treatment

Cuprizone treatment increased the number of astrocytes, microglia, and pro-inflammatory cytokine levels in the hippocampus. Cuprizone-treated mice show symptoms similar to several neurodegenerative disorders such as severe status spongiosus.

ExcerptReferenceRelevance
"Cuprizone-treated animals showed multiple deficits in short touchscreen-based operant tasks: they responded more slowly to visual stimuli, rewards and made more errors in a simple rule-learning task."( Cognitive disturbances in the cuprizone model of multiple sclerosis.
Forsman, M; Kärkkäinen, AM; Kaye, J; Kopanitsa, MV; Koponen, J; Lehtimäki, KK; Merenlender-Wagner, A; Nurmi, A; Orbach, A; Pavlidi, P; Piiponniemi, TO; Shatillo, A; Suhonen, A; Sweeney, PJ, 2021
)
1.63
"Cuprizone treatment for 8 weeks increased the number of astrocytes, microglia, and pro-inflammatory cytokine levels in the hippocampus."( Cuprizone Affects Hypothermia-Induced Neuroprotection and Enhanced Neuroblast Differentiation in the Gerbil Hippocampus after Ischemia.
Choi, JH; Hahn, KR; Hwang, IK; Jung, HY; Kim, DW; Kim, JW; Kim, TH; Kim, W; Kwon, HJ; Nam, SM; Yoo, DY; Yoon, YS, 2020
)
2.72
"Cuprizone treatment induced no changes in mechanonociception or motor performance."( Behavioural alterations and morphological changes are attenuated by the lack of TRPA1 receptors in the cuprizone-induced demyelination model in mice.
Ábrahám, H; Ács, P; Berente, Z; Bölcskei, K; Komoly, S; Kriszta, G; Payrits, M; Pintér, E; Sághy, É; Sipos, É; Vranesics, A, 2018
)
1.42
"Nine cuprizone-treated animals received daily injections of polyprenols intraperitoneally at a dose of 12-mg/kg body weight during Weeks 6-10."( Plant polyprenols reduce demyelination and recover impaired oligodendrogenesis and neurogenesis in the cuprizone murine model of multiple sclerosis.
Glazacheva, VY; Khodanovich, MY; Krutenkova, EP; Pan, ES; Pishchelko, AO; Trusov, VB; Yarnykh, VL, 2019
)
1.18
"Cuprizone treatment impairs visual function, which was demonstrated by multifocal electroretinograms, an established non-invasive method, and Dock3 overexpression prevented this effect."( Dock3 protects myelin in the cuprizone model for demyelination.
Harada, C; Harada, T; Kimura, A; Matsumoto, Y; Namekata, K; Yoshida, H, 2014
)
1.41
"Cuprizone treatment induced spongiosis and astrocyte proliferation as indicated by glial fibrillary acidic protein (Gfap) transcriptional activation and immunohistochemistry."( Comparative prion disease gene expression profiling using the prion disease mimetic, cuprizone.
Aiken, JM; Herbst, AJ; Moody, LR; Vanderloo, JP; Yoo, HS,
)
1.08
"Cuprizone-treated mice show symptoms similar to several neurodegenerative disorders such as severe status spongiosus."( Cuprizone neurotoxicity, copper deficiency and neurodegeneration.
Benetti, F; Carbonera, D; Ceola, S; D'Angelo, P; Maffia, M; Mammi, S; Salmini, B; Salvato, B; Spisni, E; Urso, E; Ventura, M; Zitolo, A, 2010
)
2.52
"Upon cuprizone treatment, mice developed a pronounced astrocytosis, with brain oedema and spongiosis characterised by vacuolisations of the neuropil predominantly in the white matter."( Copper and zinc dismetabolism in the mouse brain upon chronic cuprizone treatment.
Beltramini, M; Mauri, PL; Messori, L; Piccioli, F; Raso, M; Wittkowski, W; Zambenedetti, P; Zatta, P, 2005
)
1.02
"Cuprizone treatment of C57BL/6 mice was a highly reproducible model of CNS white matter demyelination and remyelination affecting the corpus callosum (CC)."( Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum.
Armstrong, RC; Cross, AH; Liang, HF; Song, SK; Sun, SW; Trinkaus, K, 2006
)
1.36
"Most cuprizone-treated animals exhibited generalized tonic-clonic seizures upon stress-inducing stimuli."( Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice.
Gröticke, I; Hoffmann, K; Lindner, M; Löscher, W; Stangel, M, 2008
)
1.06
"In cuprizone-treated mice, high levels of both IGF-I mRNA and peptide were expressed by astrocytes in areas of myelin breakdown."( Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination.
Bondy, CA; Hudson, LD; Komoly, S; Webster, HD, 1992
)
0.8
"Mice treated with cuprizone and polyprenols did not show significant demyelination and differences in oligodendrogenesis and neurogenesis as compared with the controls."( Plant polyprenols reduce demyelination and recover impaired oligodendrogenesis and neurogenesis in the cuprizone murine model of multiple sclerosis.
Glazacheva, VY; Khodanovich, MY; Krutenkova, EP; Pan, ES; Pishchelko, AO; Trusov, VB; Yarnykh, VL, 2019
)
1.05

Bioavailability

ExcerptReferenceRelevance
"The bioavailability of endothelial nitric oxide (NO) is regulated by transition metals but their mechanisms of action on NO synthesis and degradation are not clearly understood."( [Transition metals and nitric oxide production in human endothelial cells].
Brunet, A; David-Dufilho, M; Devynck, J; Devynck, MA; Privat, C; Richard, MJ, 2001
)
0.31
" To determine the contribution of microglia to motor function during CPZ-induced demyelination, the microglia of mice in the CPZ-model were depleted using PLX3397 (PLX), an orally bioavailable selective colony stimulating factor 1 receptor inhibitor."( Microglial depletion exacerbates axonal damage and motor dysfunction in mice with cuprizone-induced demyelination.
Haruta, C; Iwasa, K; Maruyama, K; Yamagishi, A; Yamamoto, S; Yoshikawa, K, 2023
)
1.14

Dosage Studied

ExcerptRelevanceReference
" Rats were dosed with 35 mg/kg HCP for 5 days followed by drug withdrawal for 7 days suffered spongy changes to the white matter of the cerebrum, cerebellum, medulla oblongata, and spinal cord that were accompanied by degeneration of oligodendroglia."( Hexachlorophene and cuprizone induce the spongy change of the developing rat brain by different mechanisms: the role of 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNPase).
Kanno, T; Kawasako, K; Sasaki, S; Tsuchitani, M; Yamada, N, 2012
)
0.7
" The cerebella of the mice were dissected and processed for immunohistochemistry, immunofluorescence (frozen), western blotting and dosage of cytokines (Elisa)."( Involvement of AMPK, IKβα-NFκB and eNOS in the sildenafil anti-inflammatory mechanism in a demyelination model.
Barbosa, KP; da Cruz-Höfling, MA; Luna, RL; Nunes, AK; Peixoto, CA; Rapôso, C; Rocha, SW, 2015
)
0.42
" Following testing a series of doses of cuprizone, 400 mg/kg/day was found to be the best dosage to induce dramatic and consistent demyelination after 5 weeks of administration; while remyelination quickly occurred after 9 days of cuprizone withdrawal."( An Alternative Cuprizone-Induced Demyelination and Remyelination Mouse Model.
Liu, A; Lu, J; Tattersall, D; Wang, J; Zhang, W; Zhen, W,
)
0.75
" CPZ short-term exposure with a higher dosage may offer a useful model to study some aspects of schizophrenia and evaluate the efficacy of antipsychotics."( The antipsychotic-like effects of clozapine in C57BL/6 mice exposed to cuprizone: Decreased glial activation.
Chang, H; Chen, Y; Cong, H; Du, L; Geng, X; Wei, Y; Yin, L; Zhang, X, 2019
)
0.75
" Siponimod treatment of demyelinated tadpoles improved remyelination in comparison to control in a bell-shaped dose-response curve."( Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic Models.
Akbar, D; Albrecht, P; Beckmann, N; Beerli, C; Bigaud, M; Dietrich, M; Gliem, M; Göttle, P; Gruchot, J; Hartung, HP; Hecker, C; Issberner, A; Köhrer, K; Küry, P; Langui, D; Levkau, B; Lubetzki, C; Martin, E; Meuth, SG; Nasiri, M; Petzsch, P; Ramseier, P; Shimshek, D; Stankoff, B; Stark, H; Tisserand, S; Zalc, B, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organooxygen compoundAn organochalcogen compound containing at least one carbon-oxygen bond.
organonitrogen compoundAny heteroorganic entity containing at least one carbon-nitrogen bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
methanol and methylamine oxidation to formaldehyde1315
superpathway of C1 compounds oxidation to CO22232
methylamine degradation I812

Research

Studies (813)

TimeframeStudies, This Drug (%)All Drugs %
pre-199044 (5.41)18.7374
1990's14 (1.72)18.2507
2000's104 (12.79)29.6817
2010's414 (50.92)24.3611
2020's237 (29.15)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.92 (24.57)
Research Supply Index6.72 (2.92)
Research Growth Index5.52 (4.65)
Search Engine Demand Index64.19 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (41.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.12%)5.53%
Reviews33 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other791 (95.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]